Showing 1,961 - 1,980 results of 44,189 for search '"In Treatment"', query time: 0.12s Refine Results
  1. 1961
  2. 1962

    Enhancement of Sansevieria Trifasciata Laurentii Fiber Properties with Liquid Smoke Treatment by Mukhlis Muslimin, Willy Artha Wirawan, Mohammad Muzni Harbelubun, Abdul Rifais Mujawal, R. A. Ilyas, Mohd Nor Faiz Norrrahim, Victor Feizal Knight

    Published 2025-12-01
    “…In addition, LS treatment introduces C=C and C=O functional groups into the STLF molecular chain, potentially improving the interfacial bonding between the fiber and the polymer matrix.…”
    Get full text
    Article
  3. 1963

    Impact of Comorbidities on Prognosis and Treatment Outcomes in Elderly Patients with Hodgkin Lymphoma by Dávid Tóthfalusi, Boglárka Dobó, Fanni Borics, László Imre Pinczés, Árpád Illés, Zsófia Miltényi

    Published 2025-01-01
    “…<b>Conclusions</b>: Comorbidities play a greater role in prognosis than chronological age, emphasizing the need for personalized treatment approaches.…”
    Get full text
    Article
  4. 1964

    Treatment of a Prolonged Air Leak with Radiotherapy: A Case Report by Erdoğan Çetinkaya, M. Akif Özgül, Şule Gül, Ertan Çam, Yakup Büyükpolat

    Published 2012-01-01
    “…Depending on the severity of the pneumothorax, treatment consists of oxygen therapy, simple aspiration, tube thoracostomy, and pleurodesis. …”
    Get full text
    Article
  5. 1965
  6. 1966

    Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment by Robert Brown, Marco Donia, Simon Turcotte, George Coukos, John Mullinax, Brian Gastman, James C Yang, Michael T Lotze, John B A G Haanen, Inge Marie Svane, Stephanie L Goff, Vernon K Sondak, Maartje W Rohaan, Michal Besser, Benjamin Creelan

    Published 2025-01-01
    “…In a first for solid cancers, cellular immunotherapy has entered standard of care in the treatment of patients with metastatic melanoma. The infusion of autologous tumor-infiltrating T lymphocytes (TIL) is capable of mediating durable tumor regression and is now Food and Drug Administration-approved for patients with disease refractory to immune checkpoint inhibitors. …”
    Get full text
    Article
  7. 1967

    Luminescence of copper-doped α-quartz crystal after oxygen treatment by A. Trukhin

    Published 2025-02-01
    “…Treatment of copper-doped natural α-quartz in oxygen atmosphere at 1200 °C leads to changes in luminescence properties. …”
    Get full text
    Article
  8. 1968

    Pouchitis unveiled: exploring clinical features, diagnosis, and cutting-edge treatments by Francesca Lusetti, Camilla Almeida Martins Helfenberger, Munique Kurtz de Mello, Natália Sousa Freitas Queiroz

    Published 2025-01-01
    “…Traditionally the mainstay treatment of acute pouchitis involves the use of antibiotics, but one-fifth of patients develop chronic pouchitis (CP), which may be dependent or resistant to antibiotics, posing significant challenges in the management of this condition. …”
    Get full text
    Article
  9. 1969
  10. 1970
  11. 1971

    Surgical Treatment Outcomes of Unresolved Osgood-Schlatter Disease in Adolescent Athletes by Frederick Mun, William L. Hennrikus

    Published 2021-01-01
    “…The purpose of this case series is to report the outcomes of ossicle excision and tubercleplasty for unresolved Osgood-Schlatter disease that has failed conservative treatment in six adolescent athletes. A retrospective chart review was completed, and data collected include age at onset of symptoms, age at surgery, sex, laterality, mechanism of injury, conservative treatment regimen, radiographic findings, sports played, time to return to sport, length of follow-up, and Lysholm score. …”
    Get full text
    Article
  12. 1972

    Cervical artery dissection: ethiopathogenesis, symptoms, diagnosis and treatment (literature review) by I. Zagorskienė, A. Paplauskaitė, J. Valaikienė

    Published 2020-09-01
    “…Unfortunately, no consensus is made for the first-line treatment yet. Endovascular treatment is an alternative option for selected patients. …”
    Get full text
    Article
  13. 1973

    Efficacy of Alginate-Antacid Medication in the Treatment of Patients with Gastroesophageal Reflux Disease by O. A. Storonova, A. S. Trukhmanov, V. T. Ivashkin

    Published 2018-11-01
    “…In this work, we aim to analyze the efficacy of treatment for heartburn and pathological gastroesophageal refluxes (GERs) using alginate-antacid medication. …”
    Get full text
    Article
  14. 1974
  15. 1975

    Intragastric botulinum toxin injection: a promising alternative for obesity treatment? by Hakan Balbaloglu, Ilhan Tasdoven, Ipek Yorgancioglu

    Published 2024-10-01
    “…More studies are needed to assess the treatment’s efficacy in obesity.…”
    Get full text
    Article
  16. 1976

    Lingual Leishmaniasis Presenting to Maxillofacial Surgery in UK with Successful Treatment with Miltefosine by K. Kassam, R. Davidson, P. J. Tadrous, M. Kumar

    Published 2013-01-01
    “…The patient responded excellently to miltefosine treatment, with no reactivation during followup. To the authors’ knowledge, it is the first such case of successful miltefosine treatment in this unusual variant of leishmaniasis occurring on the tongue.…”
    Get full text
    Article
  17. 1977

    Impact of Combined Antiretroviral Treatment (cART) on Latent Cytomegalovirus Infection by Aura Temereanca, Luminita Ene, Gratiela Tardei, Camelia Grancea, Cristian L. Achim, Simona Ruta

    Published 2025-01-01
    “…Patients with immunological treatment success (CD4 > 350 cells/mL) had significantly lower CMV IgG titers compared to those with suboptimal immune response to cART. …”
    Get full text
    Article
  18. 1978

    Photocatalytic Treatment of Shower Water Using a Pilot Scale Reactor by Yash Boyjoo, Ming Ang, Vishnu Pareek

    Published 2012-01-01
    “…Treatment of shower water deserves special consideration for reuse not only because of its low pollutant loading but also because it is produced in large quantities. …”
    Get full text
    Article
  19. 1979
  20. 1980

    Cell therapy for scleroderma: progress in mesenchymal stem cells and CAR-T treatment by Liting Chen, Rongshan Huang, Chaoshuo Huang, Guiming Nong, Yuanyuan Mo, Lvyin Ye, Kunhong Lin, Anping Chen, Anping Chen

    Published 2025-01-01
    “…Although cell therapy has opened new avenues for the precision treatment of scleroderma, it still faces numerous challenges. …”
    Get full text
    Article